High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$234K
$234,129
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-04-01 | $771 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-04-01 | $31,188 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-04-01 | $3,113 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-04-01 | $6,997 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-04-01 | $10,096 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-04-01 | $10,858 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-04-01 | $6,197 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-04-01 | $6,189 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-04-01 | $2,318 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $1,562 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $5,442 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $1,557 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $3,898 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $2,342 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $1,565 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $7,836 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $7,060 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $8,640 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $5,506 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $1,575 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $15,779 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-03-02 | $15,786 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $3,897 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $786 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $1,573 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $788 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $9,342 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $44,321 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $7,766 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $785 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $776 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $2,350 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $783 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $3,907 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-09 | $780 | S | Form 4 |